RadioMedix lands $40M Series A investment to advance cancer treatments


RadioMedix focuses on treatments for rare and aggressive cancers, specifically developing and advancing targeted alpha therapy and radiopharmaceuticals.

Previous Tyler's Choice Health at Home acquires Arizona firm to further expansion across Southwestern US
Next Encompass Health to add new hospital in Southeast